These alterations, particularly the more common ones in EGFR and PDGFRA, serve as valuable diagnostic markers.1,2 The diagnosis of GBM has shifted from histological evaluation to molecular genetics evaluation. This evidence concerns the gene PDGFRA and glioblastoma.